Polyamine uptake in cultured astrocytes: characterization and modulation by protein kinases.
The properties and regulation of the polyamine transport system in brain are still poorly understood. The present study shows, for the first time, the existence of a polyamine transport system in cerebellar astrocytes and suggests that polyamine uptake is mediated by a single and saturable high-affinity transport system for putrescine, spermine, and spermidine (K:(m) = 3.2, 1.2, and 1.8 microM:, respectively). Although substitution of NaCl by choline chloride produced a decrease in the putrescine, spermine, and spermidine uptake, it seems that polyamine transport in cerebellar astrocytes is not mediated by an Na(+) cotransport as in the presence of Na(+) and cholinium, polyamine uptake was much lower than when measured in a sucrose-based medium. On the other hand, ouabain, gramicidin (a Na(+) ionophore), and ionomycin (a Ca(2+) ionophore) produced a strong inhibition of polyamine uptake, suggesting that membrane potential could have an important role in the functioning of the astroglial polyamine uptake system. Moreover, protein kinase C inhibition produced an enhancement of polyamine uptake, whereas stimulation of protein kinase C with phorbol esters inhibited polyamine uptake. Alternatively, the tyrosine kinase inhibitor genistein caused a marked reduction in the uptake. No effects on polyamine uptake were observed with inhibitors and activators of cyclic AMP-dependent protein kinase or when Ca(2+)/calmodulin-dependent protein kinase II was inhibited with KN-62. These results suggest that the polyamine uptake system in cerebellar astrocytes could be modulated by protein kinase C and tyrosine kinase activities.
Dot
J
J
Departamento de Bioquímica y Biología Molecular, Universidad Autónoma de Barcelona, Cerdanyola del Valles, Barcelona, Spain.
Lluch
M
M
Blanco
I
I
Rodríguez-Alvarez
J
J
D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000378:metabolism*; D001667:Binding, Competitive / Q000187:drug effects; D015317:Biogenic Polyamines / Q000378:metabolism / Q000493:pharmacokinetics*; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005110:Extracellular Space / Q000378:metabolism; D017136:Ion Transport / Q000187:drug effects; D007476:Ionophores / Q000494:pharmacology; D051379:Mice; D010766:Phosphorylation / Q000187:drug effects; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism* / Q000494:pharmacology; D011700:Putrescine / Q000378:metabolism / Q000493:pharmacokinetics; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D013095:Spermidine / Q000378:metabolism / Q000493:pharmacokinetics; D013096:Spermine / Q000378:metabolism / Q000493:pharmacokinetics; D013696:Temperature; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D015317:Biogenic Polyamines; D004791:Enzyme Inhibitors; D007476:Ionophores; D047428:Protein Kinase Inhibitors; D013096:Spermine; D012964:Sodium; D011494:Protein Kinases; D000254:Sodium-Potassium-Exchanging ATPase; D013755:Tetradecanoylphorbol Acetate; D013095:Spermidine; D011700:Putrescine